RCEL – avita medical, inc. (US:NASDAQ)

News

AVITA Medical: Pre-J.P. Morgan Update Highlights 2025 Revenue Growth, New Debt Facility, and 2026 Growth Outlook
AVITA Medical Announces Changes to its Board of Directors [Yahoo! Finance]
AVITA Medical Announces Changes to its Board of Directors
Avita Medical (NASDAQ:RCEL) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
AVITA Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com